Bactericidal activity of levofloxacin against Streptococcus pneumoniae in an in-vitro model simulating serum pharmacokinetic parameters

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. C, 1999, Pages 71-75

  Shah, P M ^a   Schwarzel R ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; LEVOFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; BACTERICIDAL ACTIVITY; CONFERENCE PAPER; DILUTION; DRUG HALF LIFE; HUMAN; HUMAN EXPERIMENT; MEMBRANE FILTER; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TIME;

ANTI-INFECTIVE AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; OFLOXACIN; PENICILLIN RESISTANCE; SERUM BACTERICIDAL TEST; STREPTOCOCCUS PNEUMONIAE;

EID: 0344689916     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Sanfilippo, A. & Morvillo, E. (1968). An experimental model for the study of the antibacterial activity of the sulfonamides. Chemotherapy 13, 54-60.
2. Sanfilippo, A. & Schioppacassi, G. (1973). New approach to the evaluation of antibacterial activity of aminosidine. Chemotherapy 18, 297-303.
3. Grasso, S., Meinardi, G., de Carneri, I. & Tamassia, V. (1978). New in vitro model to study the effect of antibiotic concentration and rate of elimination on antimicrobial activity. Antimicrobial Agents and Chemotherapy 13, 570-6.
4. Heussel, H. (1978). In-vitro effect of constant and varying concentrations of β-lactam-antibiotics on bacteria. I. Quantitative studies on the kinetics of bactericidal effects. Zantralblatt für Bakteriologie Mikrobiologie und Hygiene. I. Abteilung, Originale A. 242, 375-86.
5. Shah, P. M. (1980). An improved method to study antibacterial activity of antibiotics in an in vitro model simulating serum levels. Methods and Findings in Experimental and Clinical Pharmacology 2, 171-6.
6. Bauernfeind, A. (1992). Bactericidal activity of antibiotics alone and in combination against Enterococcus faecalis in a pharmacodynamic model. Clinical Infectious Diseases 15, 481-5.
7. Bauernfeind, A., Kljucar, S., Schweighart, S. & Eberlein, E. (1994). Bactericidal kinetics of high dosing of intravenous ciprofloxacin in a pharmacodynamic model. In Program and Abstracts of the Fifth European Congress on Clinical Microbiology and Infectious Diseases, Oslo. Abstract P6, p. 1700. The European Society of Clinical Microbiology and Infectious Diseases.
8. Kang, S. L., Ryback, M. J., McGrath, B. J., Kaatz, G. W. & Seo, S. M. (1994). Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphytococcus aureus in an in vitro infection model. Antimicrobial Agents and Chemotherapy 38, 2702-9.
9. Wiedemann, B., Rustige-Wiedemann, C. & Kratz, B. (1994). Comparison of the pharmacodynamic properties of quinolones. In Program and Abstracts of the Fifth International Symposium on New Quinolones, Singapore. Abstract 67. p. 84.
10. Yamane, N., Jones, R. N., Frei, R., Hoban, D. J., Pignatari, A. C. & Marco, F. (1994). Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin. Journal of Chemotherapy 6, 83-91.
11. Davis, R. & Bryson, H. M. (1994). Levofloxacin, A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 47, 677-700.
12. Fish, D. N. & Chow, A. T. (1997). The clinical pharmacokinetics of levofloxacin. Clinical Pharmacokinetics 32, 101-19.
13. Barry, A. L., Fuchs, P. C., Allen, S. D., Brown, S. D., Jorgensen, J. H. & Tenover, F. C. (1996). In-vitro susceptibility of Streptococcus pneumoniae to the D-and L-isomers of ofloxacin: interpretive criteria and quality control limits. Journal of Antimicrobial Chemotherapy 37, 365-9.
14. Eliopoulos, G. M., Wennersten, C. B. & Moellering, R. C. (1996). Comparative in vitro activity of levofloxacin and ofloxacin against Gram-positive bacteria. Diagnostic Microbiology and Infectious Disease 25, 35-41.
15. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1995). Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 35, 230-2.
16. Baquero, F., Barrett, J. F., Courvalin, P., Morrissey, I., Piddock, L. & Novick, W. J. (1998). Epidemiology and mechanisms of resistance among respiratory tract pathogens. Clinical Microbiology and infection 4, Suppl. 2, S19-26.
17. Baquero, F. (1996). Epidemiology and management of penicillin-resistant pneumococci. Current Opinion in Infectious Diseases 9, 372-9.
18. Goldstein, F. W. & Acar, J. F. (1996). Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-1993 western Europe and USA collaborative surveillance study. The Alexander Project Collaborative Group. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 71-84.
19. Frémaux, A., Sissla, G. & Geslin, P. (1997). In vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. In Program and Abstracts of the Eighth European Congress of Clinical Microbiology and Infectious Diseases, Lausanne, 1997. Abstract P1147. Clinical Microbiology and Infection 3, Suppl. 2, 282.
20. Shah, P. M. (1981). Bactericidal activity of ceftazidime against Pseudomonas aeruginosa under conditions simulating serum pharmacokinetics. Journal of Antimicrobial Chemotherapy 8, Suppl. B, 135-40.
21. Vömel, W. (1965). Experimentelle grundlagen der entwicklung antibakterieller chemotherapeutika. Therapiewoche 15, 1081-6.
22. Shah, P. M. (1984). Bactericidal activity of continuously changing cefotaxime concentrations in human blood. Journal of Antimicrobial Chemotherapy 14, Suppl. B, 103-8.
23. Shah, P. M. (1985). Activity of imipenem in an in-vitro model simulating pharmacokinetic parameters in human blood. Journal of Antimicrobial Chemotherapy 15, Suppl. A, 153-7.
24. Shah, P. M., Schafer, V., Hubener, T., Metz, C. & Stille, W. (1987). Bactericidal activity of ofloxacin versus roxithromycin in the treatment of Streptococcus pneumoniae. Drugs 34, Suppl. 1, 9-13.
25. Isert, D., Lentz, K. & Markus, A. (1994). Bactericidal activity of levofloxacin and other quinolones against Streptococcus pneumoniae in a pharmacokinetic in vitro model simulating human serum levels after oral dosing. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract E17, p. 16. American Society for Microbiology, Washington, DC.